Healthcare >> CEO Interviews >> November 24, 2003
DENNY WILLSON is President and Chief Executive Officer of Cytokine
PharmaSciences Inc. He was one of the Founders of the company when it
was formed 11 years ago and assumed the CEO position in June 2002. Mr.
Willson graduated summa cum laude from the University of Notre Dame in
1973 and received his Law degree from the University of California,
Hastings College of the Law, in 1976. After practicing law for several
years, he accepted a management position with Abbott Laboratories in
Buenos Aires, Argentina. He left Abbott in 1985 to join Rorer
International where he was Managing Director of Rorer's Spanish
Affiliate in Madrid from 1986 until 1990, when Rorer was acquired by
Rhone-Poulenc (now Aventis). He was Executive Vice President of
Carrington Laboratories in Dallas, Texas, for two years before joining
with Richard Storm to found Cytokine PharmaSciences in 1992. He is a
member of the Board of Directors of both Cytokine PharmaSciences and
International Therapeutics, Inc., a Seattle antiviral company. Mr.
Willson contributes to various charitable endeavors, including Living
Bridges, an organization dedicated to impoverished children in Latin
America. Profile
PharmaSciences?
Mr. Willson: We are a pharmaceutical development company. We take
revenues from an approved product
